The goal: to accelerate groundbreaking research in cancer.

Since cancer strikes Georgians with greater ferocity than it does the citizens of many other states - both in the number of cases diagnosed and the number of deaths attributed to this terrible disease, the Georgia Cancer Coalition is highlighting several clinicians, scientists and other researchers (also know as the Georgia Cancer Coalition Scholars) sponsored by the organization.

Georgia Tech's Georgia Cancer Coalition Scholars include: Ravi V. Ballamkonda, PhD; Nathan J. Bowen, PhD; Erin B. Dickerson, PhD; Yuhong Fan, PhD; Melissa L. Kemp, PhD; Valeria Tohver Milam, PhD; Shuming Nie, PhD; Marion B. Sewer, PhD; Francesca Storici, PhD; Dongmei Wang, PhD; and Ming Yuan, PhD.

Cancer research at Georgia Tech is conducted across the disciplines among scientists in areas from biology to computing and biomedical engineering to electrical engineering.

Georgia Tech and Emory University operate a joint department in biomedical engineering where faculty at both institutions regularly collaborate on cancer research.

The National Cancer Institute (NCI) of the National Institute of Health selected Georgia Tech and Emory as one of seven National Centers of Cancer Nanotechnology Excellence (CCNE). The center, named Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology is housed in both the Emory Winship Cancer Institute and on the Georgia Tech campus and functions as a 'discovery accelerator' to integrate nanotechnology into personalized cancer treatments and early detection.

Since its inception in 2001, the Georgia Cancer Coalition has funded more than
$50 million in cancer research in our state. Distinguished Cancer Clinicians and Scholars have generated about $244 million in federal and private funds for cancer research in Georgia and eight out of every ten scholars have written at least one article ranking in the top ten of the most-cited research in their fields of study.